IM Cannabis Corp ( (TSE:IMCC) ) just unveiled an announcement.
In March 2025, IM Cannabis Corp. launched several high-THC premium cannabis strains in Israel, including ‘ESPRESSO CNDY’ and ‘MED CO T15’. The company is focused on maximizing revenue and margins by managing its international assets and supply chain. It is also seeking new strategic investments and growth opportunities in Israel and Germany. The company faces challenges due to global economic conditions, including inflation and supply chain disruptions, as well as political instability in Israel and the ongoing Israel-Hamas conflict, which have impacted its operations. However, the anticipated medical cannabis regulatory reform in Israel is expected to positively impact the company’s business by making medical cannabis more accessible and boosting exports.
More about IM Cannabis Corp
IM Cannabis Corp. operates within the cannabis industry, focusing on the cultivation and distribution of cannabis products. The company is actively involved in the medical cannabis distribution and retail segments in Israel and is expanding its operations in Germany. It aims to leverage its expertise to establish leadership in the European medical cannabis market and prepare for the recreational market following legalization.
YTD Price Performance: -30.70%
Average Trading Volume: 11,734
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.76M
See more data about IMCC stock on TipRanks’ Stock Analysis page.